Emla and Anzemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emla (lidocaine; prilocaine) and Anzemet (dolasetron mesylate). Common drug interactions include malaise among females and pulmonary embolism among males.

The phase IV clinical study analyzes what interactions people have when they take Emla and Anzemet. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

On Jul, 17, 2026

24 people who take Emla and Anzemet together, and have interactions are studied.

What are the common drug interactions of Emla and Anzemet, by gender? *:

female:

Malaise (a feeling of general discomfort or uneasiness)
Anaphylactic reaction (serious allergic reaction)
Bradycardia (abnormally slow heart action)
Dizziness
Abdominal pain
Abdominal pain lower
Alopecia (absence of hair from areas of the body)
Anaemia (lack of blood)
Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
Arteriopathic disease (an impairment of the structure or function of the blood vessels which carry blood away from the heart)

male:

Pulmonary embolism (blockage of the main artery of the lung)

What are the common drug interactions of Emla and Anzemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Depressed level of consciousness
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Lymphangitis (inflammation of the lymph channel)
Malaise (a feeling of general discomfort or uneasiness)
Syncope vasovagal (malfunction in the parts of the nervous system leads to consciousness with an inability to maintain postural tone)
Anaphylactic reaction (serious allergic reaction)

60+:

Pulmonary embolism (blockage of the main artery of the lung)
Abdominal pain
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Diarrhoea
Disease progression
Dry skin
Epistaxis (bleed from the nose)
Erythema (redness of the skin)
Face oedema (swelling of face)
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Sleep Disorder: 17 people, 70.83%
Nausea (feeling of having an urge to vomit): 17 people, 70.83%
Muscle Spasms (muscle contraction): 17 people, 70.83%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 17 people, 70.83%
Depression: 17 people, 70.83%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 17 people, 70.83%
Non-Small Cell Lung Cancer Stage Iv: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Emla and Anzemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously